Expression of hedgehog signalling pathway in anaplastic thyroid cancer

Endocrine

Volumn 45, Issue 3, 2014, Pages 439-447

  Hinterseher, Ulrike ^a   Wunderlich, Annette ^a   Roth, Silvia ^a   Ramaswamy, Annette ^a   Bartsch, Detlef K ^a   Hauptmann, Stefan ^b   Greene, Brandon H ^c   Fendrich, Volker ^a   Hoffmann, Sebastian ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Anaplastic thyroid cancer; Cyclopamine; Hedgehog signalling pathway; MTA

Indexed keywords

CYCLOPAMINE; PROTEIN PATCHED; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLI1 PROTEIN, HUMAN; MESSENGER RNA; PATCHED RECEPTORS; SHH PROTEIN, HUMAN; SMO PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER; VERATRUM ALKALOID;

ANAPLASTIC THYROID CANCER; ARTICLE; CANCER CELL; CANCER GROWTH; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; IC50; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; THYROID CARCINOMA; TUMOR CELL LINE;

CELL LINE, TUMOR; HEDGEHOG PROTEINS; HUMANS; INHIBITORY CONCENTRATION 50; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; THYROID CARCINOMA, ANAPLASTIC; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; VERATRUM ALKALOIDS;

EID: 84897056885     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0015-y     Document Type: Article

References (43)

1. B. Aschebrook-Kilfoy, M.H. Ward, M.M. Sabra, S.S. Devesa, Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 21(2), 125-134 (2011). doi:10.1089/thy.2010.0021
2. F. Perri, G.D. Lorenzo, G.D. Scarpati, C. Buonerba, Anaplastic thyroid carcinoma: a comprehensive review of current and future therapeutic options. World J. Clin. Oncol. 2(3), 150-157 (2011). doi:10.5306/wjco.v2.i3.150
3. Y.H. Bian, S.H. Huang, L. Yang, X.L. Ma, J.W. Xie, H.W. Zhang, Sonic hedgehog-Gli1 pathway in colorectal adenocarcinomas. World J. Gastroenterol. 13(11), 1659-1665 (2007)
4. J. Dong, M.R. Gailani, S.L. Pomeroy, D. Reardon, A.E. Bale, Identification of PATCHED mutations in medulloblastomas by direct sequencing. Hum. Mutat. 16(1), 89-90 (2000). doi:10.1002/1098-1004(200007)16:1〈89:AID- HUMU18〉3.0.CO;2-7
5. L. Ghali, S.T. Wong, J. Green, N. Tidman, A.G. Quinn, Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin. J. Invest. Dermatol. 113(4), 595-599 (1999). doi:10.1046/j.1523-1747.1999.00729.x
6. K.T. Jang, K.T. Lee, J.G. Lee, S.H. Choi, J.S. Heo, D.W. Choi, G. Ahn, Immunohistochemical expression of Sonic hedgehog in intraductal papillary mucinous tumor of the pancreas. Appl. Immunohistochem. Mol. Morphol. 15(3), 294-298 (2007). doi:10.1097/01.pai.0000213132.71041.da
7. M.S. Liu, P.Y. Yang, T.S. Yeh, Sonic hedgehog signalling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma. Pancreas 34(3), 340-346 (2007). doi:10.1097/mpa.0b013e3180333ab5
8. Z. Yuan, J.A. Goetz, S. Singh, S.K. Ogden, W.J. Petty, C.C. Black, V.A. Memoli, E. Dmitrovsky, D.J. Robbins, Frequent requirement of hedgehog signalling in non-small cell lung carcinoma. Oncogene 26(7), 1046-1055 (2007). doi:10.1038/sj.onc.1209860
9. J.E.S. Hooper, M.P. Scott, The drosophila patched gene encodes a putative membrane protein required for segmental patterning. Cell 59(4), 751-765 (1989)
10. V. Marigo et al., Biochemical evidence that patched is the hedgehog receptor. Nature 384, 177-179 (1996)
11. P.T. Chuang, A.P. McMahon, Vertebrate hedgehog signalling modulated by induction of a hedgehog-binding protein. Nature 397(6720), 617-621 (1999). doi:10.1038/17611
12. L.V. Goodrich, L. Milenkovic, K.M. Higgins, M.P. Scott, Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277(5329), 1109-1113 (1997)
13. A. Ruiz i Altaba, C. Mas, B. Stecca, The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 17(9), 438-447 (2007). doi:10.1016/j.tcb.2007.06.007
14. B. Stecca, I.A.A. Ruiz, Context-dependent regulation of the GLI code in cancer by hedgehog and non-hedgehog signals. J. Mol. Cell Biol. 2(2), 84-95 (2010). doi:10.1093/jmcb/mjp052
15. H. Kimura, D. Stephen, A. Joyner, T. Curran, Gli1 is important for medulloblastoma formation in Ptc1 ± mice. Oncogene 24(25), 4026-4036 (2005). doi:10.1038/sj.onc.1208567
16. N. Dahmane, J. Lee, P. Robins, P. Heller, A. Ruiz i Altaba, Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389(6653), 876-881 (1997). doi:10.1038/39918
17. K.K. Nelson, P. Gattuso, X. Xu, R.A. Prinz, Expression of the sonic hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy. Surgery 148(4), 654-660 (2010). doi:10.1016/j.surg.2010.07.030. discussion 660
18. X. Xu, H. Ding, G. Rao, S. Arora, C.P. Saclarides, J. Esparaz, P. Gattuso, C.C. Solorzano, R.A. Prinz, Activation of the Sonic hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr. Relat. Cancer 19(2), 167-179 (2012). doi:10.1530/erc-11-0305
19. J. Taipale, J.K. Chen, M.K. Cooper, B. Wang, R.K. Mann, L. Milenkovic, M.P. Scott, P.A. Beachy, Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 406(6799), 1005-1009 (2000). doi:10.1038/35023008
20. D.M. Berman, S.S. Karhadkar, A.R. Hallahan, J.I. Pritchard, C.G. Eberhart, D.N. Watkins, J.K. Chen, M.K. Cooper, J. Taipale, J.M. Olson, P.A. Beachy, Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297(5586), 1559-1561 (2002). doi:10.1126/science.1073733
21. S.P. Thayer, M.P. di Magliano, P.W. Heiser, C.M. Nielsen, D.J. Roberts, G.Y. Lauwers, Y.P. Qi, S. Gysin, C. Fernandez-del Castillo, V. Yajnik, B. Antoniu, M. McMahon, A.L. Warshaw, M. Hebrok, Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425(6960), 851-856 (2003). doi:10.1038/nature02009
22. M. Lauth, A. Bergstrom, T. Shimokawa, R. Toftgard, Inhibition of GLI-mediated transcription and tumor cell growth by smallmolecule antagonists. Proc. Natl. Acad. Sci. USA 104(20), 8455-8460 (2007). doi:10.1073/pnas. 0609699104
23. N.E. Heldin, B. Westermark, The molecular biology of the human anaplastic thyroid carcinoma cell. Thyroidology 3(3), 127-131 (1991)
24. A. Steg, H.M. Amm, Z. Novak, A.R. Frost, M.R. Johnson, Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer. Cancer Biol. Ther. 10 (9), 893-902 (2010). doi:10.4161/cbt.10.9.13252
25. S.M. Wiseman, O.L. Griffith, S. Deen, A. Rajput, H. Masoudi, B. Gilks, L. Goldstein, A. Gown, S.J. Jones, Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch. Surg. 142(8), 717-727 (2007). doi:10.1001/archsurg.142.8.717. discussion 727-719
26. A.R. Jonckheere, A distribution-free k-sample test against ordered alternatives. Biometrica 41, 133-145 (1954)
27. M.H. Hasler, L.A. Hothorn, Multiple contrast tests in the presence of heteroscedasticity. Biom. J. 50, 793-800 (2008)
28. N. Ting (ed.), Dose finding in drug developement (Springer, New York, 2006)
29. R. Bhattacharya, J. Kwon, B. Ali, E. Wang, S. Patra, V. Shridhar, P. Mukherjee, Role of hedgehog signalling in ovarian cancer. Clin. Cancer Res. 14(23), 7659-7666 (2008). doi:10.1158/1078-0432.ccr-08-1414
30. V. Dormoy, S. Danilin, V. Lindner, L. Thomas, S. Rothhut, C. Coquard, J.J. Helwig, D. Jacqmin, H. Lang, T. Massfelder, The sonic hedgehog signalling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol. Cancer 8, 123 (2009). doi:10.1186/1476-4598-8-123
31. G.A. Raz, K.E. Allen, C. Kingsley, I. Cherni, S. Arora, A. Watanabe, C.D. Lorenzo, V.D.K. Edwards, S. Sridhar, G. Hostetter, G.J. Weiss, Hedgehog signalling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer. Lung Cancer 76(2), 191-196 (2011)
32. V. Fendrich, J. Waldmann, F. Esni, A. Ramaswamy, M. Mullendore, M. Buchholz, A. Maitra, G. Feldmann, Snail and Sonic hedgehog activation in neuroendocrine tumors of the ileum. Endocr. Relat. Cancer 14(3), 865-874 (2007). doi:10.1677/erc-07-0108
33. D.M. Berman, S.S. Karhadkar, A. Maitra, R. Montes De Oca, M.R. Gerstenblith, K. Briggs, A.R. Parker, Y. Shimada, J.R. Eshleman, D.N. Watkins, P.A. Beachy, Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425(6960), 846-851 (2003). doi:10.1038/ nature01972
34. D.N. Watkins, D.M. Berman, S.G. Burkholder, B. Wang, P.A. Beachy, S.B. Baylin, Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422(6929), 313-317 (2003). doi:10.1038/ nature01493
35. L. Mao, Y.P. Xia, Y.N. Zhou, R.L. Dai, X. Yang, S.J. Duan, X. Qiao, Y.W. Mei, B. Hu, H. Cui, A critical role of Sonic Hedgehog signalling in maintaining the tumorigenicity of neuroblastoma cells. Cancer Sci. 100(10), 1848-1855 (2009). doi:10.1111/j.1349-7006.2009.01262.x
36. T. Kawahara, N. Kawaguchi-Ihara, Y. Okuhashi, M. Itoh, N. Nara, S. Tohda, Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res. 29(11), 4629-4632 (2009)
37. P.M.R. LoRusso, C.M. Rudin, J.R. Reddy et al., Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin. Cancer Res. 17(8), 2502-2511 (2011)
38. E.A. Barnes, K.J. Heidtman, D.J. Donoghue, Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC. Oncogene 24(5), 902-915 (2005). doi:10.1038/sj.onc.1208240
39. J. Reifenberger, M. Wolter, C.B. Knobbe, B. Kohler, A. Schonicke, C. Scharwachter, K. Kumar, B. Blaschke, T. Ruzicka, G. Reifenberger, Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br. J. Dermatol. 152(1), 43-51 (2005). doi:10.1111/j.1365-2133.2005. 06353.x
40. O. Munoz, F. Fend, R. de Beaumont, H. Husson, A. Astier, A.S. Freedman, TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation. Leukemia 18(12), 2015-2025 (2004). doi:10.1038/sj.leu. 2403485
41. E.G. Rizzatti, R.P. Falcao, R.A. Panepucci, R. Proto-Siqueira, W.T. Anselmo-Lima, O.K. Okamoto, M.A. Zago, Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3 K-AKT, WNT and TGFbeta signalling pathways. Br. J. Haematol. 130(4), 516-526 (2005). doi:10.1111/j.1365-2141.2005.05630.x
42. S. Dennler, J. Andre, I. Alexaki, A. Li, T. Magnaldo, P. ten Dijke, X.J. Wang, F. Verrecchia, A. Mauviel, Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3- dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 67(14), 6981-6986 (2007). doi:10.1158/0008-5472.can-07-0491
43. R. Elisei, Anaplastic thyroid cancer therapy: dream or reality? Endocrine 42(3), 468-470 (2012)